Erlanger Medical Center, Tennessee
Tia Collier, PharmD, BCCCP is the Medical and Neuroscience ICU Clinical Pharmacist at Erlanger Health System in Chattanooga, Tennessee, where she also serves as the Residency Program Director for the PGY2 Critical Care Pharmacy Residency. In her dual role, Dr. Collier provides specialized pharmacotherapy expertise for critically ill patients and mentors pharmacy residents pursuing advanced training in critical care.
Dr. Collier earned her Doctor of Pharmacy degree from the University of Mississippi School of Pharmacy in 2017. She went on to complete her PGY1 Pharmacy Practice Residency at the University of Mississippi Medical Center in Jackson, Mississippi in 2018, followed by a PGY2 Critical Care Pharmacy Residency at Baylor University Medical Center in Dallas, Texas in 2019.
Following her postgraduate training, Dr. Collier joined UNC Health REX in Raleigh, North Carolina, where she served as the Medical/Surgical ICU Clinical Pharmacist and the PGY2 Critical Care Pharmacy Residency Program Director. During her five years at UNC Health REX, she helped expand and strengthen the residency program while optimizing medication management for critically ill patients through evidence-based practice, interdisciplinary collaboration, and continuous quality improvement initiatives.
Dr. Collier is a Board-Certified Critical Care Pharmacist (BCCCP) and an active advocate for professional development within the pharmacy community. Currently, she serves as the Outreach Chair of the Southeastern SCCM Chapter. Her professional interests include sepsis management, alcohol withdrawl, and optimizing sedation and analgesia practices in the ICU. She is passionate about advancing pharmacy practice through education, mentorship, and research aimed at improving outcomes for critically ill patients.
In her spare time, Dr. Collier enjoys traveling, scuba diving, and spending time with friends, family, and her cat Tori.
Comparison of Olive Oil-Based Versus Soybean Oil-Based Lipid Emulsions With Parenteral Nutrition
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Hemodynamic Impact of Albumin Timing Post-Initial Fluid  Resuscitation in Septic Shock
Monday, March 23, 2026
10:15 AM - 11:15 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Impact of Lowered Sliding-Scale Insulin Treatment Thresholds on Glycemic Control
Monday, March 23, 2026
11:30 AM - 12:30 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
